- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2365-421X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Good practices for 68Ga radiopharmaceutical production ; volume:7 ; number:1 ; day:22 ; month:10 ; year:2022 ; pages:1-26 ; date:12.2022
EJNMMI radiopharmacy and chemistry ; 7, Heft 1 (22.10.2022), 1-26, 12.2022
- Urheber
-
Nelson, Bryce J. B.
Andersson, Jan D.
Wuest, Frank
Spreckelmeyer, Sarah
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41181-022-00180-1
- URN
-
urn:nbn:de:101:1-2023010621022633646290
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nelson, Bryce J. B.
- Andersson, Jan D.
- Wuest, Frank
- Spreckelmeyer, Sarah
- SpringerLink (Online service)
Ähnliche Objekte (12)
Good practices for 89Zr radiopharmaceutical production and quality control
Good practices for Ga-68 radiopharmaceutical production: an important correction
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Production and separation of 43Sc for radiopharmaceutical purposes
Position statement on radiopharmaceutical production for clinical trials
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Technetium : chemistry and radiopharmaceutical applications
Radiopharmaceutical tracers for cardiac imaging
Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production
Good practices for 89Zr radiopharmaceutical production and quality control
Good practices for Ga-68 radiopharmaceutical production: an important correction
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Production and separation of 43Sc for radiopharmaceutical purposes
Position statement on radiopharmaceutical production for clinical trials
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Technetium : chemistry and radiopharmaceutical applications
Radiopharmaceutical tracers for cardiac imaging
Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production
Good practices for 89Zr radiopharmaceutical production and quality control
Good practices for Ga-68 radiopharmaceutical production: an important correction
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Production and separation of 43Sc for radiopharmaceutical purposes
Position statement on radiopharmaceutical production for clinical trials
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices
Production of non carrier added (n.c.a.) 177Lu for radiopharmaceutical applications
A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Technetium : chemistry and radiopharmaceutical applications
Radiopharmaceutical tracers for cardiac imaging